OraSure Rapid HIV Test Kits and Associated Quality Controls

The state of Idaho, specifically the Division of Public Health, is seeking procurement of OraSure Rapid HIV Test Kits and Associated Quality Controls through a competitive solicitation process. This contract opportunity, identified by the unique ID 67c07369d1021ad253035974, was posted on February 26, 2025, with proposals due by April 2, 2025. The procurement appears focused on acquiring specialized medical diagnostic testing equipment and associated quality control materials specifically designed for HIV testing. Potential vendors must demonstrate comprehensive capabilities in providing rapid HIV test kits that meet clinical standards and include necessary quality control mechanisms. The solicitation likely requires vendors to provide detailed technical specifications, proof of FDA approval, demonstrated reliability of test kits, and comprehensive quality assurance documentation. Potential respondents will need to showcase their technical competence, manufacturing capabilities, product certifications, and ability to meet the precise requirements of the Idaho Division of Public Health.

While specific set-aside designations are not explicitly detailed in the provided information, state procurement typically includes provisions for disadvantaged business enterprises or small business participation. The contract appears designed for medical supply vendors with specialized expertise in diagnostic testing equipment, particularly those with established track records in HIV testing technologies. Potential respondents should anticipate a competitive evaluation process that may include detailed technical review, pricing assessment, vendor qualifications, and compliance with state procurement regulations. Although specific budget ranges are not specified, medical diagnostic procurement contracts of this nature typically range from moderate to significant financial values, potentially between $50,000 to $500,000 depending on volume and specific requirements. Vendors should be prepared to demonstrate robust supply chain capabilities, consistent product quality, potential volume discounting, and ability to meet ongoing public health testing needs for the state of Idaho.